Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
What Does Spx Level Tell You About Market distills the level into actionable insights about market breadth and momentum.
28,520 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
AST SpaceMobile surged last month, with spacemobile stock zoomed 53.5% sparking investor chatter. This article breaks...
In volatile markets, simplicity often wins. Here’s why I’m focusing on these only cryptocurrencies comfortable—Bitcoi...
Two giants dominate the S&P 500 ETF space, but only one may fit your approach. This guide breaks down IVV vs VOO with...
A practical look at how Leopold Aschenbrenner's Situational Awareness guides bets on AI infrastructure. Learn what to...
Micron stock bounced back today as AI demand and memory pricing expectations shift. This article breaks down why MU m...
When a top actor questions late-night formats, it isn’t just showbiz drama. It’s a cautionary tale about revenue shif...
AMD investors face a bumpy road as market reality clashes with AI optimism. This guide explains what unfortunate news...
Beaten-down brands aren’t a bet on luck—they’re a test of resilience. This piece explores two stocks down right hold ...
When work ends, the clock starts on an 8-month window to enroll in Medicare Part B without penalties. Missing it can ...
Turnaround stories can create powerful upside for patient investors, but they also open doors for short sellers who b...